Christiana Stamoulis
Director of Finance/CFO at INCYTE CORPORATION
Net worth: 9 M $ as of 2024-03-30
Profile
Presently, Christiana Stamoulis is Chief Financial Officer & Executive Vice President of Incyte Corp. Ms. Stamoulis is also on the board of Hologic, Inc. In her past career she was President & Chief Financial Officer at Cogent Biosciences, Inc., Senior VP-Strategy & Business Development at Vertex Pharmaceuticals, Inc., Managing Director-Investment Banking Division at Citigroup, Inc. and Vice President at Goldman Sachs & Co. LLC. Ms. Stamoulis received an undergraduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
INCYTE CORPORATION
0.04% | 2024-02-13 | 89,983 ( 0.04% ) | 5 M $ | 2024-03-30 |
HOLOGIC, INC.
0.02% | 2024-03-06 | 45,472 ( 0.02% ) | 4 M $ | 2024-03-30 |
Christiana Stamoulis active positions
Companies | Position | Start |
---|---|---|
HOLOGIC, INC. | Director/Board Member | 2011-10-31 |
INCYTE CORPORATION | Director of Finance/CFO | 2019-02-10 |
Former positions of Christiana Stamoulis
Companies | Position | End |
---|---|---|
COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 2019-01-30 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2013-11-30 |
CITIGROUP INC. | Corporate Officer/Principal | 2008-12-31 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Training of Christiana Stamoulis
Massachusetts Institute of Technology | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
HOLOGIC, INC. | Health Technology |
INCYTE CORPORATION | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
CITIGROUP INC. | Finance |
COGENT BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
- Stock Market
- Insiders
- Christiana Stamoulis